From: Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression
Variable | Subject group | |
---|---|---|
Control subjects (n = 157) | Multiple sclerosis (n = 118) | |
Gender (M/F) | 40/117 | 38/80 |
Age (years) | 40 ± 15.23 | 31.3 ± 9.14 |
Disease duration (years) | N/A | 7 ± 5.86 |
EDSS | N/A | 1.25 ± 0.74 |